Liquid biopsy is a non-invasive diagnostic tool that uses circulating tumor DNA (ctDNA), circulating tumor cells, or other tumor-derived components in blood plasma to determine cancer genetic status. Though liquid biopsy's minimal invasiveness and temporal resolution are appealing, the small quantity of ctDNA in plasma creates difficulty.
Liquid biopsies can assist doctors in early cancer detection and stratification, real-time monitoring of therapy response and resistance mechanisms in the tumor, assessing the likelihood of metastatic relapse, and predicting the outcome.
Cancer therapy might be controlled by liquid biopsies. They might also be the optimal scheme for precision medicine in therapy personalization. It is the most cutting-edge approach in the field of medical oncology. It has tremendous potential as a tool for cancer screening and early detection, as well as the ability to analyze a patient's state after diagnosis and recurrence, and the efficacy of real-time therapy in various cancer kinds. The limitations of tissue biopsies can be solved by liquid biopsy. Circulating tumor cells, circulating tumor nucleic acids, free of cells or enclosed in exosomes, microvesicles, and platelets make up the liquid biopsy. Liquid biopsy investigations are done on a variety of biofluids retrieved in a non-invasive manner, including blood, urine, saliva, and cerebrospinal fluid.
Group Futurista is excited to announce the “Future of Liquid Biopsy for Precision Oncology” Summit.
You can grab your passes for free!
Topic We Cover
CXO, VP, Director, Head, Manager & Specialist of -
This is an online event. You do not have to travel to any specific location. You can participate from your convenient location. The virtual event is accessible from a computer, mobile and tablet devices.
Your login details will be emailed to you ahead of the event. You can use those details to access the online event.
Absolutely. We are counting on you to invite others! Help us spread the word. You can simply share the link to this page, and they can register at their convenience.